Stock PFE PFIZER, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Calendar Pfizer, Inc.

Equities

PFE

US7170811035

Market Closed - Nyse
Other stock markets
 04:00:25 2024-05-10 pm EDT 		5-day change 1st Jan Change
28.01 USD -0.60% Intraday chart for Pfizer, Inc. +0.72% -2.71%
May. 09 HLS Therapeutics Meets Q1 Earnings Forecast, But Misses on Revs; Lowers 2024 Vascepa Guidance MT
May. 08 Sector Update: Health Care Stocks Softer Late Afternoon MT

Chart calendar Pfizer, Inc.

798bfb81492c626b3e4ae155e.OAF3MvlGlBcaAHL457f3Zi2jR3p1BJeHwWAdnLHz7_Y.cUVAYqsC5mZUVwa1ldiVB3SQNTIabtnkkwN6xsi-nZ5iMDtDrS3cRltOQg~e40a430f02eadfedbd92552e67ebb4fa

Upcoming events on Pfizer, Inc.

2024-05-31 03:45 pm American Society of Clinical Oncology Annual Meeting - Abstract No: LBA8503
2024-06-01 10:00 am American Society of Clinical Oncology Annual Meeting - Abstract No: 3108
2024-06-01 04:00 pm American Society of Clinical Oncology Annual Meeting - Abstract No: LBA7005
2024-06-01 04:00 pm American Society of Clinical Oncology Annual Meeting - Abstract No: 5005
2024-06-01 04:00 pm American Society of Clinical Oncology Annual Meeting - Abstract No: 3006
2024-06-01 05:30 pm American Society of Clinical Oncology Annual Meeting - Abstract No: 8521
2024-06-02 10:00 am American Society of Clinical Oncology Annual Meeting - Abstract No: 4563
2024-06-02 10:00 am American Society of Clinical Oncology Annual Meeting - Abstract No: 4562
2024-06-02 10:00 am American Society of Clinical Oncology Annual Meeting - Abstract No: 5063
2024-06-02 10:00 am American Society of Clinical Oncology Annual Meeting - Abstract No: 5061
2024-06-02 10:00 am American Society of Clinical Oncology Annual Meeting - Abstract No: 5021
2024-06-02 10:00 am American Society of Clinical Oncology Annual Meeting - Abstract No: 1105
2024-06-02 10:00 am American Society of Clinical Oncology Annual Meeting - Abstract No: 1111
2024-06-03 09:00 am American Society of Clinical Oncology Annual Meeting - Abstract No: 4503
2024-06-03 09:00 am American Society of Clinical Oncology Annual Meeting - Abstract No: 4502

Past events on Pfizer, Inc.

2024-05-08 Ex-dividend day
2024-05-01 10:00 am Q1 2024 Earnings Call
2024-05-01 06:45 am Q1 2024 Earnings Release
2024-04-25 09:00 am Annual General Meeting
2024-03-12 08:00 am Leerink Partners Global Biopharma Conference
2024-03-04 11:10 am TD Cowen Health Care Conference
2024-02-29 01:00 pm Investor Day - Oncology Innovation
2024-01-30 10:00 am Q4 2023 Earnings Call
2024-01-30 06:45 am Q4 2023 Earnings Release
2024-01-24 Ex-dividend day
2024-01-08 06:00 pm JPMorgan Healthcare Conference
2023-12-13 08:30 am Q4 2024 Guidance Call
2023-12-11 08:15 pm American Society of Hematology Meeting - Abstract Number -1054
2023-12-11 07:30 pm American Society of Hematology Meeting - Abstract Number -1057
2023-12-09 07:45 pm American Society of Hematology Meeting - Abstract Number -274
2023-12-09 07:30 pm American Society of Hematology Meeting - Abstract Number -285
2023-12-09 12:45 pm American Society of Hematology Meeting - Abstract Number -14
2023-11-28 10:50 am Evercore ISI HealthCONx Conference
2023-11-09 12:35 pm Truist Securities Healthcare Conference
2023-11-08 Ex-dividend day

Past dividends on Pfizer, Inc.

2024-05-08 Quarterly 0.42 USD
2024-01-24 Quarterly 0.42 USD
2023-11-08 Quarterly 0.41 USD
2023-07-26 Quarterly 0.41 USD
2023-05-10 Quarterly 0.41 USD
2023-01-25 Quarterly 0.41 USD
2022-11-02 Quarterly 0.4 USD
2022-07-27 Quarterly 0.4 USD
2022-05-11 Quarterly 0.4 USD
2022-01-26 Quarterly 0.4 USD

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million USD		Released
Forecast
Spread 		51 750
51 807
-0.11%		41 908
48 014
-12.72%		81 288
81 781
-0.6%		100 330
100 373
-0.04%		58 496
59 105
-1.03%
60 407

EBITDA
Million USD		Released
Forecast
Spread 		21 097
22 824
-7.57%		17 801
21 398
-16.81%		25 426
29 444
-13.65%		42 336
44 597
-5.07%		15 590
11 249
38.59%
21 189

EBIT
Million USD		Released
Forecast
Spread 		19 420
19 883
-2.33%		13 024
17 362
-24.99%		20 235
26 662
-24.11%		37 272
40 403
-7.75%		9 300
8 509
9.3%
17 050

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		17 682
22 426
-21.15%		7 497
13 166
-43.06%		24 311
19 569
24.23%		34 729
39 058
-11.08%		1 058
2 301
-54.02%
11 020

Net income
Million USD		Released
Forecast
Spread 		16 273
19 053
-14.59%		9 616
16 066
-40.15%		21 979
22 567
-2.6%		31 372
33 053
-5.09%		2 119
3 040
-30.29%
7 775

EPS
USD		Released
Forecast
Spread 		2,87
3,40
-15.62%		1,71
3,07
-44.24%		3,85
3,89
-0.9%		5,47
5,85
-6.45%		0,37
0,72
-48.44%
1,44

Announcement Date28/01/2002/02/2108/02/2231/01/2330/01/24-

Quarterly results

Fiscal PeriodDecember 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2
Net sales
Million USD		Released
Forecast
Spread 		25 661
24 734
3.75%		27 742
26 199
5.89%		22 638
21 091
7.33%		24 290
24 393
-0.42%		18 282
16 488
10.88%		12 734
13 398
-4.96%		13 232
13 429
-1.47%		14 249
14 396
-1.02%		14 879
13 923
6.87%
13 050


14 847


17 770


15 680


13 725

EBITDA
Million USD		Released
Forecast
Spread 		11 135
13 710
-18.78%		13 583
12 434
9.25%		10 325
10 332
-0.06%		6 772
7 436
-8.92%		7 857
7 513
4.58%		4 925
4 000
23.13%		-1 244
-1 511
17.64%		1 340
-1 298
203.24%
4 403


3 759


4 681


4 537







EBIT
Million USD		Released
Forecast
Spread 		9 948
9 738
2.16%		12 408
11 055
12.24%		9 142
9 092
0.55%		5 253
6 886
-23.71%		6 370
6 471
-1.56%		3 319
3 634
-8.68%		-1 625
-1 827
11.07%		-330
-1 404
76.5%		5 912
3 667
61.24%
3 423


3 804


3 977







Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		9 050








5 231
7 425
-29.55%





-3 352
2 207
-251.88%		-4 129
-3 139
-31.54%		3 421
2 992
14.34%
1 962


2 926


3 380







Net income
Million USD		Released
Forecast
Spread 		7 864
8 418
-6.58%		9 906
9 799
1.09%		8 608
7 631
12.8%		4 995
5 667
-11.86%		5 543
4 495
23.31%		2 327


-2 382
-3 241
26.49%		-3 369
-2 371
-42.12%		3 115
1 951
59.69%
1 496


2 046


2 679







EPS
USD		Released
Forecast
Spread 		1,37
1,60
-14.17%		1,73
1,64
5.73%		1,51
1,37
10.21%		0,87
0,69
25.48%		0,97
0,85
14.79%		0,41


-0,42
-0,51
16.83%		-0,60
-0,43
-41.06%		0,55
0,34
61.01%
0,25


0,36


0,47







Announcement Date03/05/2228/07/2201/11/2231/01/2302/05/2301/08/2331/10/2330/01/2401/05/24-----

Upcoming sector events for Pfizer, Inc.

2024-05-12 PHARMANUTRA S.P.A.: Q1 2024 Earnings Release
2024-05-12 AARTI PHARMALABS LIMITED: Q4 2024 Earnings Release
2024-05-12 ROHTO PHARMACEUTICAL CO.,LTD.: Q4 2023 Earnings Release
2024-05-12 SHIONOGI & CO., LTD.: Q4 2023 Earnings Release
2024-05-12 MOCHIDA PHARMACEUTICAL CO., LTD.: Q4 2023 Earnings Release
2024-05-12 SAWAI GROUP HOLDINGS CO., LTD.: Q4 2023 Earnings Release
2024-05-12 MEGA LIFESCIENCES: Q1 2024 Earnings Release
2024-05-12 ALMIRALL, S.A.: Q1 2024 Earnings Release
2024-05-12 JW PHARMACEUTICAL CORPORATION: Q1 2024 Earnings Release (Projected)
2024-05-12 DONGKOOK PHARMACEUTICAL CO., LTD.: Q1 2024 Earnings Release (Projected)
More events

Past sector events for Pfizer, Inc.

2024-05-10 11:01 am PIRAMAL PHARMA LIMITED: Q4 2024 Earnings Release
2024-05-10 06:50 am ANI PHARMACEUTICALS, INC.: Q1 2024 Earnings Release
2024-05-10 06:46 am NEULAND LABORATORIES LIMITED: Q4 2024 Earnings Release
2024-05-09 NIPPON SHINYAKU CO., LTD.: Q4 2023 Earnings Release
2024-05-09 KYORIN PHARMACEUTICAL CO., LTD.: Q4 2023 Earnings Release
2024-05-09 JCR PHARMACEUTICALS CO., LTD.: Q4 2023 Earnings Release
2024-05-09 TTY BIOPHARM COMPANY LIMITED: Q1 2024 Earnings Release (Projected)
2024-05-09 04:02 pm COLLEGIUM PHARMACEUTICAL, INC.: Q1 2024 Earnings Release
2024-05-09 09:58 am SCINOPHARM TAIWAN, LTD.: April 2024 Sales and Revenue Release
2024-05-09 09:06 am ABBOTT INDIA LIMITED: Q4 2024 Earnings Release

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. PFE Stock
  4. Calendar Pfizer, Inc.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW